Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ANGO Stock Annual Income Statement. Download in Excel

AngioDynamics Inc. logo

AngioDynamics Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

10.81
 
USD
  
0.15
  
(1.41%)
Previous close: 10.66  Open: 10.68  Bid: 10.4  Ask: 11.63
52 week range    
5.47   
   13.50
Mkt Cap: 452 M  Avg Vol (90 Days): 551,406
Last updated: Tuesday 17th June 2025

Stock Rankings

61
MarketXLS Rank
60
Value
72
Technical
52
Quality
How are these ranks calculated?
Search for a stock

Financials

ANGO Income Statement

Annual
May-15May-16May-17May-18May-19May-20May-21May-22May-23May-24
AcquiredInProcessRnD10 M
AcquiredInProcessRnDIncome-8 M
Amortization of intangibles18 M18 M17 M14 M17 M18 M18 M20 M19 M13 M
Basic EPS from continuing operations-0.17-0.3-4.39-0.82-0.68-1.33-4.59
Basic EPS total-0.09-1.210.140.441.63-4.39-0.82-0.68-1.33-4.59
Basic weighted shares outstanding36 M36 M37 M37 M37 M38 M38 M39 M39 M40 M
BasicDiscontinuousOperations0.611.93
Cost of sales-181 M-180 M-173 M-118 M115 M114 M134 M150 M165 M149 M
Depreciation-10 M-8 M-6 M-3 M3 M3 M6 M8 M12 M15 M
Depreciation unreconciled18 M18 M17 M14 M17 M18 M18 M20 M19 M13 M
DepreciationAndAmortization18 M18 M17 M14 M17 M18 M18 M20 M19 M13 M
Diluted EPS total-0.09-1.210.140.441.63-4.39-0.82-0.68-1.33-4.59
Diluted normalized net income/share-0.17-0.3-4.39-0.82-0.68-1.33-4.59
Diluted weighted shares outstanding36 M36 M37 M37 M37 M38 M38 M39 M39 M40 M
DilutedDiscontinuousOperations0.611.93
Earnings from equity interest-36 M
EarningsFromEquityInterestNetOfTax-36 M
GainOnSaleOfPPE-168 M54 M
GeneralAndAdministrativeExpense29 M31 M31 M31 M35 M38 M36 M38 M40 M41 M
Gross operating profit176 M174 M144 M144 M156 M150 M157 M166 M174 M155 M
ImpairmentOfCapitalAssets159 M15 M159 M
Income before tax-8 M-3 M10 M-17 M-15 M-168 M-36 M-30 M-54 M-192 M
Income restructuring and M&A-1 M-5 M288000.026000.0
Income taxes-5 M40 M5 M-11 M-4 M-1 M-5 M-3 M-2 M-7 M
Interest income4000.011000.0
InterestExpenseNonOperating3 M3 M3 M3 M5 M907000.0861000.0688000.03 M-2 M
MiscOtherSpecialCharges-10 M-886000.010 M-31000.0-15 M-130000.092000.0-790000.0-554000.0-817000.0
Net income from total operations-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M-184 M
NetIncomeCommonStockholders-12 M-47 M15 M-23 M-9 M-167 M-32 M-27 M-34 M-184 M
NetIncomeContinuousOperations-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M-184 M
NetIncomeDiscontinuousOperations23 M72 M
NetNonOperatingInterestIncomeExpense-3 M-3 M-3 M-3 M-5 M-907000.0-861000.0-688000.0-3 M2 M
Normalized income-93 M
Operating income-3 M1 M13 M-14 M-9 M-167 M-35 M-28 M-51 M-192 M
Operating income before depreciation (EBITDA)25 M28 M37 M9 M16 M-143 M-9 M88000.0-21 M-166 M
OperatingExpense-179 M-173 M-163 M-158 M165 M317 M192 M184 M225 M402 M
Other income net10 M886000.0-10 M17 M15 M130000.0-92000.0-11 M554000.0-54 M
OtherGainLossFromDispositionOfDiscontinuedOperations72 M
OtherGandA29 M31 M31 M31 M35 M38 M36 M38 M40 M41 M
OtherImpairmentOfCapitalAssets-100000.0
OtherOperatingExpenses22 M16 M10 M16 M-8 M6 M-20 M3 M3 M3 M
OtherWriteDown900000.0
RealizedCapitalGain7 M
RentAndLandingFees29 M31 M31 M31 M3 M
Research & development expense27 M25 M25 M24 M28 M30 M36 M31 M30 M32 M
ResearchExpense27 M25 M25 M24 M28 M30 M36 M31 M30 M32 M
RestructringAndMnAIncome-1 M-5 M288000.026000.0
Revenue per share18 M18 M17 M14 M17 M18 M18 M20 M19 M13 M
SalariesAndWages-6 M-3 M-6 M-8 M-2 M-2 M-2 M-2 M-3 M-2 M
Selling Gen & administrative expense112 M114 M110 M104 M112 M117 M117 M134 M144 M144 M
SellingAndMarketingExpense83 M84 M79 M73 M77 M79 M81 M95 M104 M103 M
SellingExpense83 M84 M79 M73 M
Special income/charges1 M5 M-288000.0-159 M-15 M-159 M
Total Income available for interest expense (EBIT)-5 M132000.013 M-14 M-10 M-167 M-35 M-29 M-52 M-193 M
Total common shares outstanding36 M36 M37 M37 M37 M38 M38 M39 M40 M40 M
Total net income-12 M-47 M15 M-23 M61 M-167 M-32 M-27 M-52 M-184 M
Total ordinary shares41 M41 M41 M41 M41 M41 M41 M41 M41 M41 M
Total revenues357 M354 M350 M262 M271 M264 M291 M316 M339 M304 M
TotalExpenses-360 M-353 M-337 M-276 M280 M431 M326 M334 M390 M551 M
TotalRevenue357 M354 M270 M262 M271 M264 M291 M316 M339 M304 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader